Cotter
Anthony J. Cotter, Ballincollig IE
Patent application number | Description | Published |
---|---|---|
20150295832 | MULTI-CARRIER LOAD-BALANCING - Methods, systems, and computer readable media can be operable to perform load-balancing across a plurality of channels based upon a likelihood of a load imbalance occurring across the plurality of channels. Service flows can be configured to use one or more channels of a plurality of channels based upon determinations of a minimum and/or a maximum bandwidth potential of each of the plurality of channels. | 10-15-2015 |
Bronwyn Nicola Cotter, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20100170509 | BREATHING ASSISTANCE APPARATUS - A pressure regulating device includes a housing having a gases inlet adapted to in use be in fluid communication or integrated with a breathing assistance apparatus which conveys gases to an infant or a neonate requiring breathing assistance, an outlet adapted to be in use in fluid communication with said infant, and an aperture which enables the venting of a portion of gases that in use are passing through the housing from the inlet to the outlet. A tube inlet on the housing is adapted to receive a surfactant delivery device therethrough to enable administration of surfactant to the infant or neonate. A sealing mechanism seals around the surfactant delivery device and is adapted to normally fluidically seal the tube inlet and in use allow the surfactant delivery device to pass through the tube inlet. | 07-08-2010 |
Finbarr Edward Cotter, London GB
Patent application number | Description | Published |
---|---|---|
20120101115 | Compounds For Inducing Cellular Apoptosis - The present invention provides isoquinoline, tetrahydroisoquinoline and tetrahydropyridopyrimidine compounds that induce cell death by apoptosis and uses of the compounds in medicine, especially their use for treating cancer and other diseases. | 04-26-2012 |
Jeffrey Cotter, Gilmore AU
Patent application number | Description | Published |
---|---|---|
20100058207 | Interactivity Platform System and Method - A system and method permitting each of a plurality of users to create, populate and share a decentralised virtual world using an applications platform with a peer to peer network. | 03-04-2010 |
John Cotter, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20080220997 | Solid Stick Compositions Comprising Thermosetting Plastic - The present invention provides a modified solid stick composition comprising a thermosetting plasticizer, a resin, a lubricant, a friction modifier, or a combination thereof. The solid stick compositions may be used for application between two metal surfaces in sliding and rolling-sliding contact such as steel wheel-rail systems including mass transit and freight systems. A method of reducing energy consumption, or controlling friction between a metal surface and a second metal surface by applying the solid stick composition to one or more than one of the metal surfaces, is also provided. | 09-11-2008 |
Mary A. Cotter, Aberdeen GB
Patent application number | Description | Published |
---|---|---|
20090186908 | Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy - The present invention relates to a new use of a statin drug in the improvement of diabetic neuropathy, specifically in improving nerve conduction velocity and nerve blood flow in patients suffering diabetes, in particular to pharmaceutical combinations of the statin drug and other agents known to improve diabetic neuropathy such as an aldose reductase inhibitor (ARI), an angiotensin converting enzyme (ACE) inhibitor or an angiotensin II (AII) antagonist which combinations are useful in the prevention and treatment of the complications of diabetes. | 07-23-2009 |
20120041010 | PHARMACEUTICAL COMBINATION OF (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]PYRI- MIDIN-5-YL] (3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CANDESARTAN - The present invention relates to a new use of a statin drug in the improvement of diabetic neuropathy, specifically in improving nerve conduction velocity and nerve blood flow in patients suffering diabetes, in particular to pharmaceutical combinations of the statin drug and other agents known to improve diabetic neuropathy such as an aldose reductase inhibitor (ARI), an angiotensin converting enzyme (ACE) inhibitor or an angiotensin II (AII) antagonist which combinations are useful in the prevention and treatment of the complications of diabetes | 02-16-2012 |
Paul Cotter, Dublin 14 IE
Patent application number | Description | Published |
---|---|---|
20110252297 | PERSONALISING CONTENT PROVIDED TO A USER - A method for personalizing content such as user interface items provided to a user during a session of an interactive application is disclosed. One or more environmental context attribute values for the session are determined. Responsive to a request for content, for at least one item of the content, each of the environmental context attribute values are mapped to respective values indicating a users level of interest in the item for the environmental context attribute values. Content is retrieved from a content database and the content is personalized as a function of the users level of interest in the item for the environmental context attribute values before being returned to the application. | 10-13-2011 |
Paul Cotter, Stillorgan IE
Patent application number | Description | Published |
---|---|---|
20090132368 | Systems and Methods for Providing Personalized Advertisement - A method for providing personalized advertisement to a first user. The method includes the steps of: displaying a first advertisement to users; defining segments for a user community preference; assigning each of the users to one of the segments in response to the user's level of interest in the user community preference; identifying a first group of the users interested in the first advertisement; identifying a second group of the users not interested in the first advertisement; determining the percentage of the first group of users assigned to the segment; determining the percentage of the second group of users assigned to the segment; determining whether each segment is an indicator for user interest in the first advertisement by comparing the two percentages associated with the segment; and targeting a second advertisement to users assigned to the segment if the segment is an indicator for user interest in the first advertisement. | 05-21-2009 |
20090157417 | Systems and methods for detecting click fraud - A method for detecting click fraud. In one embodiment, the method includes the steps of: directing a user to an item but delaying the internal ratings update of the item; collecting data to build a model of the user; building the model of the user in response to the collected data; determining the trustworthiness of the user in response to the model of the user; and updating internal ratings of the item in response to the trustworthiness of the user. In various embodiments, the click fraud can be the inflation of advertisement clicks, the inflation of popularity or the inflation of reputation. | 06-18-2009 |
Paul Cotter, Cork IE
Patent application number | Description | Published |
---|---|---|
20110269671 | NISIN DERIVATIVES AND THE USE THEREOF - The present invention relates to a nisin derivative comprising amino acid substitutions in the peptide sequence encoding the hinge region of the protein, wherein the derivative exhibits an increased anti-microbial activity. | 11-03-2011 |
20130005647 | MUTANT NISIN SER 29 DERIVATIVES AND THE USE THEREOF - A Nisin derivative or variant, comprising an amino acid substitution at amino acid position 29 in the amino acid sequence. The Nisin derivative exhibits enhanced antimicrobial activity when compared to wild type Nisin. The Nisin derivative has an application as a natural food additive and as a therapeutic agent. | 01-03-2013 |
Thomas Cotter, Muenchen DE
Patent application number | Description | Published |
---|---|---|
20150283538 | Alkali Metal-Modified Vanadium-Phosphorus Oxide (VPO) Catalyst - The present invention relates to a catalyst containing a vanadium-phosphorus oxide and an alkali metal, wherein the proportion by weight of alkali metal in the vanadium-phosphorus oxide is in the range from 10 to 400 ppm, based on the total weight of the vanadium-phosphorus oxide, a process for producing it and also the use of the catalyst for the gas-phase oxidation of hydrocarbons, in particular for preparing maleic anhydride. | 10-08-2015 |
Thomas Cotter, Co. Cork IE
Patent application number | Description | Published |
---|---|---|
20110136898 | TREATMENT OF RETINAL DEGENERATION - The use of a compound of general formula (I): or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of a disease or condition characterised by apoptosis or degeneration of mammalian cells, wherein: R1 is a alkoxy, alkyl, ether or ester group; R2 is H or has the formula wherein Y is linear or branched, saturated or unsaturated, aliphatic group with from 2 to 23 carbon atoms, or a cyclic group, and which can contain substituents selected from the group consisting of hydroxyl, alkoxy, amino, carboxyl, cyano, nitro, alkylsuphonyl or halogen atoms, X is O or S; and R3 is any substituent. | 06-09-2011 |
20110144077 | TREATMENT OF RETINAL DEGENERATION - The use of a compound having a gon-4-ene nucleus, said nucleus having attached thereto, in the 13 position, a polycarbon-alkyl radical having 2 to about 16 carbon atoms, said compound containing at least 19 and up to 40 carbon atoms in its carbon-carbon skeleton, in the manufacture of a medicament for the treatment or prevention of a disease or condition characterised by apoptosis or degeneration of mammalian cells. | 06-16-2011 |